CSBM

Related by string. CSBMs * * weekly CSBMs *

Related by context. Frequent words. (Click for all words.) 60 ACR# [002] 60 Secondary endpoints included 60 RECIST criteria 59 secondary endpoint 59 plus methotrexate 58 Secondary endpoints 58 mg BID 58 Secondary endpoints include 58 dyspnea 57 Postoperative 57 cytogenetic response 57 n = 57 primary efficacy endpoint 56 mcg kg 56 statistically significant reduction 56 IPSS 56 statistically significant improvement 56 RECIST 56 evaluable patients 55 55 placebo p = 55 evaluable 55 DAS# [002] 55 P = .# 54 sustained virologic response 54 annualized relapse 54 statistically significant p 54 subscales 54 p = #.# [004] 54 postoperatively 54 PANSS 54 prespecified 54 % CI #.#-#.# [006] 54 p = #.# [002] 54 virologic failure 54 confidence interval CI 53 Main Outcome Measures 53 nab paclitaxel 53 laboratory abnormalities 53 composite endpoint 53 placebo p 53 primary endpoint 53 symptom severity 53 Pharmacokinetic 53 secondary endpoints 52 peginterferon alfa 2a 52 creatinine clearance 52 mg dose 52 secondary efficacy endpoints 52 log# 52 Phase 1a 52 EDSS 52 Cmax 52 plus ribavirin 52 primary efficacy endpoints 52 nonresponders 52 ANOVA 52 limiting toxicity 52 ± SD 52 echocardiographic 51 LVEF 51 median PFS 51 histologic 51 IU mL 51 tamsulosin 51 sinus rhythm 51 copies mL 51 glomerular filtration rate 51 events AEs 51 fasting plasma glucose 51 mg/m2 51 placebo 51 rotigotine 51 noninferiority 51 HCV RNA 51 infarct size 50 randomisation 50 serum phosphorus 50 active comparator 50 hypokalemia 50 dose limiting toxicities 50 erythema 50 non inferiority 50 symptomatology 50 peginterferon 50 #mg dose [003] 50 claudication 50 oral glucose tolerance 50 Global Impression 50 FOLFOX 50 serum concentrations 50 phase IIa 50 HbA1c levels 50 primary endpoints 49 hypomagnesemia 49 FEV1 49 airflow obstruction 49 inflammatory lesions 49 ADHD RS 49 DMARD 49 febrile neutropenia

Back to home page